Overview
ENVB market data
Price History
ENVB price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ENVB. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Shares of psychedelic-related biotech companies are trading higher amid sympathy with AtaiBeckley after the company announced it will be acquired by Lilly in a deal worth up to $3.8 billion.Benzinga · Jul 16, 2026, 4:43 PM
8-K filing — Enveric Biosciences, Inc. (ENVB)SEC EDGAR · Jun 9, 2026, 9:16 PM
Enveric Biosciences Initiates Investigational New Drug-enabling Genotoxicity Studies Of EB-003Benzinga · Jun 2, 2026, 12:10 PM
Enveric Biosciences Reports Preclinical Results From Preclinical In Vitro Experiments Evaluating Photoxicity Risk, Indicates No Photoreactive Potential For EB-003Benzinga · May 19, 2026, 12:10 PM
Enveric Biosciences Q1 EPS $(1.08) Up From $(14.64) YoYBenzinga · May 15, 2026, 12:20 PM
Enveric Biosciences Receives US Patent Titled, "Carboxylated Psilocybin Derivatives And Methods Of Using," Pertaining To EVM301 Series Of Molecules Being Developed As Potential Treatments For Mental Health DisordersBenzinga · May 13, 2026, 12:07 PM